Loading...
A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody
Epitopes that are conserved among SARS-like coronaviruses are attractive targets for design of cross-reactive vaccines and therapeutics. CR3022 is a SARS-CoV neutralizing antibody to a highly conserved epitope on the receptor binding domain (RBD) on the spike protein that can cross-react with SARS-C...
Na minha lista:
| Udgivet i: | bioRxiv |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Cold Spring Harbor Laboratory
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7523114/ https://ncbi.nlm.nih.gov/pubmed/32995788 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.09.21.305441 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|